We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Lowering of Cholesterol Levels and the Risk of Stroke—Reply

John R. Crouse III, MD; Robert P. Byington, PhD; Helena M. Hoen, MS; Curt D. Furberg, MD, PhD
Arch Intern Med. 1998;158(1):99. doi:.
Text Size: A A A
Published online


In reply

Although we recognize, along with Davey Smith and Ebrahim, that there have been trials of estrogen therapy following stroke, nonetheless, we agree with others1,2 that the mechanisms of action of estrogen to reduce at least cardiovascular events may only partly relate to its cholesterol-reducing effects and may also relate to other (eg, antioxidant) effects. In viewing older clinical trials of clofibrate, it is evident that one study3 with only 95 patients would not be powered to uncover a treatment effect on stroke. Another study4 showed no effect of the intervention on stroke. As has been pointed out by Davey Smith,5 as well as referenced in our article,6 there may be agent-specific effects that promote stroke as well as reduce stroke. The challenges implicit in mounting a trial specifically designed to look at the effects of statins in stroke reduction are formidable, not the least of which is the likelihood of reaching a cardiac end point prior to a stroke end point. Of interest, since the publication of our article, a second meta-analysis of clinical trials on the use of statins for reducing stroke has been published,7 and the authors agree with our conclusions.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Quick Reference

Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed
Clarifying Your Question